Literature DB >> 8146427

The molecular genetics of steroid 5 alpha-reductases.

D W Russell1, D M Berman, J T Bryant, K M Cala, D L Davis, C P Landrum, J S Prihoda, R I Silver, A E Thigpen, W C Wigley.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8146427     DOI： 10.1016/b978-0-12-571149-4.50018-0

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN： 0079-9963


× No keyword cloud information.
  12 in total

Review 1.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

2.  Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).

Authors:  R Anwar; S G Gilbey; J P New; A F Markham
Journal:  Mol Pathol       Date:  1997-02

Review 3.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

Review 4.  Genetics of androgen metabolism in women with infertility and hypoandrogenism.

Authors:  Aya Shohat-Tal; Aritro Sen; David H Barad; Vitaly Kushnir; Norbert Gleicher
Journal:  Nat Rev Endocrinol       Date:  2015-05-05       Impact factor: 43.330

Review 5.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

Authors:  Wenqing Gao; James T Dalton
Journal:  Drug Discov Today       Date:  2007-02-07       Impact factor: 7.851

6.  The IVS1-2A>G mutation in the SRD5A2 gene predominates in Cypriot patients with 5α reductase deficiency.

Authors:  N Skordis; V Neocleous; A Kyriakou; E Efstathiou; A Sertedaki; P Philibert; L A Phylactou; S Lumbroso; C Sultan
Journal:  J Endocrinol Invest       Date:  2010-05-28       Impact factor: 4.256

7.  Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia.

Authors:  Felipe Vilchis; Evangelina Valdez; Luis Ramos; Rocio García; Rita Gómez; Bertha Chávez
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

8.  Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.

Authors:  Wenqing Gao; Jeffrey D Kearbey; Vipin A Nair; Kiwon Chung; A F Parlow; Duane D Miller; James T Dalton
Journal:  Endocrinology       Date:  2004-08-12       Impact factor: 4.736

9.  Crosstalk between normal and tumoral brain cells. Effect on sex steroid metabolism.

Authors:  R C Melcangi; I Cavarretta; V Magnaghi; M Ballabio; L Martini; M Motta
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

10.  Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells.

Authors:  John P Wiebe; Michael J Lewis
Journal:  BMC Cancer       Date:  2003-03-22       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.